Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Stock Short Interest Report for September

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the recipient of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 143,564 shares, a decrease of 46.6% from the September 15th total of 268,742 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 239,833 shares, the days-to-cover ratio is currently 0.6 days.

Analysts Set New Price Targets

Separately, Loop Capital set a $1.00 price objective on Xtant Medical in a research report on Wednesday, September 2nd. Two equities research analysts have rated the stock with a Buy rating. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $1.00.

Xtant Medical Price Performance

Shares of Xtant Medical stock traded down $0.02 during trading hours on Friday, hitting $0.29. The company’s stock had a trading volume of 97,535 shares, compared to its average volume of 641,427. The company has a market cap of $40.22 million, a PE ratio of -3.58 and a beta of -0.20. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.05 and a current ratio of 2.16. The business has a 50 day moving average price of $0.35 and a two-hundred day moving average price of $0.42. Xtant Medical has a 12-month low of $0.27 and a 12-month high of $0.95.

Xtant Medical (NYSEAMERICAN:XTNT) last released its quarterly earnings data on Tuesday, August 11th. The medical device company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.05). The company had revenue of $23.03 million for the quarter, compared to the consensus estimate of $24.88 million. Xtant Medical had a negative net margin of 10.17% and a negative return on equity of 23.45%.

Hedge Funds Weigh In On Xtant Medical

An institutional investor recently bought a new position in Xtant Medical stock. AWM Investment Company Inc. bought a new stake in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 5,976,910 shares of the medical device company’s stock, valued at approximately $2,516,000. AWM Investment Company Inc. owned about 4.26% of Xtant Medical at the end of the most recent reporting period. 69.33% of the stock is currently owned by hedge funds and other institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc is a medical technology company focused on developing, manufacturing and distributing products used in orthopedic and spinal procedures. Its portfolio is designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal structures.

The company offers a range of biologic products, including human tissue allografts, demineralized bone matrix and other bone-graft substitutes. It also provides implantable devices and surgical instruments for spine and orthopedic applications, including products used in interbody fusion and spinal fixation procedures.

Xtant Medical is headquartered in Belgrade, Montana, and serves the U.S.